Genetics of diabetes and its complications

Journal of the American Society of Nephrology

Volumn 17, Issue 2, 2006, Pages 353-360

  Rich, Stephen S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SODIUM PROTON EXCHANGE PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

CLINICAL FEATURE; DIABETIC NEPHROPATHY; DISEASE COURSE; FAMILIAL DISEASE; GENE CLUSTER; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION;

EID: 33645459779     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005070770     Document Type: Review

References (66)

1. Rewers M, LaPorte RE, King H, Tuomilehto J: Trends in the prevalence and incidence of diabetes: Insulin-dependent diabetes mellitus in childhood. World Health Stat Q 41: 179-189, 1988
2. Rewers MJ: The changing face of the epidemiology of insulin-dependent diabetes mellitus (IDDM): Research designs and models of disease causation. Ann Med 23: 419-426, 1991
3. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 31: 3160-3167, 2003
4. Pociot F, McDermott MF: Genetics of type 1 diabetes mellitus. Genes Immun 3: 235-249, 2002
5. Rich SS: Mapping genes in diabetes: A genetic epidemiological perspective. Diabetes 39: 1315-1319, 1990
6. Concannon P, Erlich HA, Julier C, Morahan G, Pociot F, Nerup J, Todd JA, Rich SS: Type 1 diabetes: Evidence for susceptibility loci from four genome-wide scans in 1435 multiplex families. Diabetes 54, 2995-3001, 2005
7. Bell GI, Polonsky KS: Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414: 788-791, 2001
8. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2002
9. Weijnen CF, Rich SS, Meigs JB, Krolewski AS, Warram JS: Risk of diabetes in siblings of index cases with type 2 diabetes: Implications for genetic studies. Diabet Med 19: 41-50, 2002
10. Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjogren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC: A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum Mol Genet 12: 1865-1873, 2003
11. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzch H, Schroder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang YQ, Xiang K, Yamagata K, Yang Y, Bell GI: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13: 161-166, 1996
12. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175, 2000
13. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: The common PPARg Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76-80, 2000
14. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman GA, Walker M, Levy JC, Sampson MJ, Halford S, McCarthy MI, Hattersley AT, Frayling TM: Large scale association studies of variants in genes encoding pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk for type 2 diabetes susceptibility. Am J Hum Genet 52: 568-572, 2003
15. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004
16. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, Hori M: Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 10: 1128-1132, 2004
17. Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, Haffner SM, Bergman RN, Bowden DW: Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 53: 3013-3019, 2004
18. Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW: Association of protein tyrosine phosphatase 1B polymorphisms with type 2 diabetes. Diabetes 53: 3007-3012, 2004
19. Bowden DW: Genetics of diabetes complications. Curr Diab Rep 2: 191-200, 2002
20. US Renal Date System: USRDS 2003 Annual Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
21. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage renal disease in IDDM: A 35-year follow-up study. Kidney Int 50: 2041-2046, 1996
22. Seaquist ER, Goetz FC, Rich SS, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
23. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722, 1992
24. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945, 1996
25. Microvascular and acute complication in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 37: 278-285, 1994
26. Fioretto P, Steffes MW, Barboso J, Rich SS, Miller ME, Mauer M: Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48: 865-869, 1999
27. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI: Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 5: 796-800, 2004
28. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, Province MA, Schwander KL, Arnett DK, Mellen BG: A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 42: 291-296, 2003
29. Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD: Genetic contribution to renal function and electrolyte balance: A twin study. Clin Sci 103: 259-265, 2002
30. DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J: A genome scan for renal function among hypertensives: The HyperGEN study. Am J Hum Genet 68: 136-144, 2000
31. Hunt SC, Hasstedt SJ, Coon H, Camp NJ, Cawthon RM, Wu LL, Hopkins PN: Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int 62: 1143-1148, 2002
32. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 273: 1516-1517, 1996
33. Alshuler D, Daly M, Kruglyak L: Guilt by association. Nat Genet 26: 135-137, 2000
34. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M: Genomewide scans of complex human diseases. True linkage is hard to find. Am J Hum Genet 69: 936-950, 2001
35. Hill AB: The environment and disease: Association or causation. Proc R Soc Med 58: 295-300, 1965
36. Clayton D, McKeigue PM: Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358: 1356-1360, 2001
37. Chakravarti A: Nature, nurture and human disease. Nature 421: 413-414, 2003
38. Caramori ML, Mauer M: Diabetes and nephropathy. Curr Opin Nephrol Hypertens 12: 273-282, 2003
39. Brownlee M, Livingston JN: Biochemical mechanisms of microvascular disease. In: Ellenberg & Rifkin's Diabetes Mellitus, 6th Ed., edited by Porte D Jr, Sherwin RS, Baron A, New York, McGraw Hill, 2003, pp 181-196
40. Du X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97: 12222-12226, 2000
41. Hugot J, Chamaillard M, Zouali H, Lesage S, Cezard J, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel J, Sahbatou M, Thomas G: Association of Nod2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-602, 2001
42. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST, Keith TP: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418: 426-430, 2002
43. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71: 337-348, 2002
44. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47: 821-830, 1998
45. Moczulski DK, Rogus JJ, Antonellis A, Warram JH: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes 47: 1164-1169, 1998
46. Vardarli I, Baier L, Hanson JA, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, Van Der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183, 2002
47. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ, Rich SS, Freedman BI: A genome scan for diabetes associated end-stage renal disease in African Americans. Kidney Int 66: 1517-1526, 2004
48. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002
49. Kriska AM, Saremi A, Hanson RL, Bennett PH, Kobes S, Williams DE, Knowler WC: Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 158: 669-675, 2003
50. Tanaka N, Babazono T, Saito S, Sekine A, Tsunoda T, Haneda M, Tanaka Y, Fujioka T, Kaku K, Kawamori R, Iwamoto Y, Nakamura Y, Maeda S: Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52: 2848-2853, 2003
51. Trevisan R, Li LK, Messent J, Tariq T, Earle K, Walker JD, Viberti G: Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41: 1239-1246, 1992
52. Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D: Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter. Kidney Int 50: 1684-1693, 1996
53. Shankland SJ, Scholey JW, Ly H, Thai K: Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 46: 430-442, 1994
54. Iwano M, Kubo A, Nishino T, Sato H, Nishoika H, Akai Y, Kurioka H, Fugii Y, Kanauchi M, Shiiki H, Doki K: Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49: 1120-1126, 1996
55. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A: The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 141: 1196-1208, 2000
56. Janssen JA, Lamberts SW: Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin Endocrinol (Oxf) 52: 1-9, 2000
57. Elliot SJ, Striker LJ, Hattori M, Yang CW, He CJ, Peten EP, Striker GE: Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. Endocrinology 133: 1783-1788, 1993
58. Lupia E, Ellit SJ, Lenz O, Zheug F, Hattori M, Striker GE, Striker J: IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: Implications for diabetic nephropathy. Diabetes 48: 1638-1644, 1999
59. Flyvbjerg A, Kessler U, Kiess W: Increased kidney and liver insulin-like growth factor II/mannose-6-phosphate receptor concentration in experimental diabetes in rats. Growth Regul 4: 188-193, 1994
60. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu S, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5: 1390-1395, 1999
61. Simon M, Rockl W, Hornig C, Grone EF, Theis H, Weich HA, Fuchs E, Vayon A, Grone HJ: Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J Am Soc Nephrol 9: 1032-1044, 1998
62. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239, 1999
63. Gruden G, Thomas S, Burt D, Zhou W, Chusney G, Gnudi L, Viberti G: Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 10: 730-737, 1999
64. Caramori MLA, Mauer M: Pathophysiology of renal complications. In: Ellenberg and Rifkin's Diabetes Mellitus, 6th Ed., edited by Porte D Jr, Sherwin RS, Baron A, New York, McGraw-Hill, 2003, pp 697-722
65. Caramori MLA, Mauer M: Diabetes and nephropathy. Curr Opin Nephrol Hypertens 12: 273-282, 2003
66. Mauer M, Zinman B, Gardiner R, Drummond KN, Suissa S, Donnelly SM, Strand TD, Kramer MS, Klein R, Sinaiko AR: ACE-1 and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 3: 262-269, 2002